Marfan Syndrome
Marfan syndrome is a genetic disorder that primarily affects the body's connective tissue, which is responsible for providing strength, support, and elasticity to the skin, blood vessels, and other tissues. This multi-systemic disorder can manifest in various body systems, most notably the skeletal, cardiovascular, and ocular systems.
The underlying cause of Marfan syndrome is mutations in the FBN1 gene, which encodes the protein fibrillin-1, a crucial component of connective tissue. This mutation leads to structural weakness in connective tissues, resulting in a wide array of physical manifestations.
Individuals with Marfan syndrome typically exhibit several distinctive physical traits:
Diagnosis of Marfan syndrome involves a combination of genetic testing and a thorough physical examination, focusing on the family history and the presence of characteristic symptoms. The Gent criteria are often used to aid in diagnosis, evaluating the involvement of different organ systems.
There is no cure for Marfan syndrome, but treatment focuses on managing symptoms and minimizing the risk of complications. Regular monitoring of the cardiovascular system is critical. Beta-blockers or angiotensin receptor blockers may be prescribed to manage cardiovascular symptoms. Surgical intervention may be necessary in cases of severe aortic dilation or dissection.
Marfan syndrome shares similarities with other connective tissue disorders, such as Ehlers-Danlos syndrome and Loeys-Dietz syndrome. These disorders also involve mutations affecting connective tissue, leading to overlapping symptoms and challenges in differential diagnosis.